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To explore the expression and gain more informa-
tion on the function of transglutaminase 5 enzyme in
normal and defective human epidermis, we gener-
ated a rat antihuman transglutaminase 5 antiserum
elicited against a puri®ed active recombinant protein
expressed in the baculovirus system. By use of
Western blotting and immuno¯uorescence methods,
the immunospeci®city of the antibodies for transglu-
taminase 5 was tested; no crossreactivity with other
transglutaminases (types 1, 2, and 3) was observed,
thus allowing histochemistry studies. By indirect
immuno¯uorescence analysis the antibodies decor-
ated the upper layers of normal human epidermis,
with consistent staining in the spinous and granular
layers. We evaluated transglutaminase 5 expression
in comparison with proliferating (keratin 14) and dif-
ferentiating (transglutaminase 3) markers in different
diseases, such as psoriasis, ichthyosis vulgaris, lamel-
lar ichthyosis, and Darier's disease. We observed that
transglutaminase 5 contributes, as a secondary effect,
to the hyperkeratotic phenotype in ichthyosis (both
vulgaris and lamellar) and in psoriasis. In Darier's
disease, transglutaminase 5 expression, as well as
transglutaminase 3, is completely missregulated,
being overexpressed or totally absent in different
areas of the same lesion. Key words: ichthyosis/keratin
14/psoriasis/transglutaminase. J Invest Dermatol 119:670±
677, 2002
T
erminal differentiation of strati®ed squamous epithe-
lia, including human epidermis, ends with the
formation of a specialized protein structure deposited
just beneath the inner surface of the cell plasma
membrane, called the corni®ed cell envelope (CE).
CE components are several epidermal speci®c structural proteins
[involucrin, cystatin A, loricrin, several small proline-rich proteins
(SPRs), trichohyalin, keratins; Rice and Green, 1979; Kartasova et
al, 1987; Mehrel et al, 1990; Takahashi et al, 1992] assembled by the
catalytic action of transglutaminase (TGase) enzymes. TGases (EC
2.3.2.13) are Ca2+-dependent crosslinking enzymes that catalyze an
acyl-transfer reaction between the g-carboxamide group of protein-
bound glutamine and various primary amines, most commonly the
e-amino group of lysine residues, thus forming isopeptide bonds
between proteins that generate insoluble macromolecular assem-
blies (Folk and Finlayson, 1977; Thacher and Rice, 1985).
Although the order of deposition of the structural proteins in the
CE has not yet been established unambiguously, much evidence
suggests that they are crosslinked by three of the seven known
TGases: TGase 1, TGase 3, and TGase 5 (Candi et al, 2001; for
review on TGases see Melino et al, 2000).
Even though the expression pattern of TGase 5 enzyme is not
restricted to the epidermis (Aeschlimann et al, 1998; 2001; Candi et
al, 2001), previous studies, by us and others (Aeschlimann et al,
1998; Candi et al, 2001), suggested that TGase 5 probably plays a
role in keratinocyte differentiation and CE assembly. Indeed,
TGase 5 transcript is induced by differentiating agents in normal
keratinocytes, and kinetic constants (Kcat/Km and Km) showed high
af®nity for TGase 5 in using loricrin, involucrin, and SPRs as
substrate.
In an attempt to investigate further the function of the novel
enzyme TGase 5 in epidermal differentiation, and to gain more
information on CE assembly, we developed an antihuman
TGase 5 antiserum immunizing two rats by injection of the
puri®ed active recombinant protein expressed in the baculovirus
system. TGase 5 is detected in the upper layers of normal
human epidermis, following a gradient of expression stretching
from the spinous layer to the horny layer. We have also
evaluated TGase 5 expression in pathologic conditions such us
psoriasis, ichthyosis (lamellar and vulgaris), and Darier's disease
(DD), comparing proliferating (keratin 14) and differentiating
(TGase 3) markers. Taken together, these data indicated that
TGase 5 is expressed in differentiating keratinocytes in vivo, and
its expression is upregulated, as a secondary effect, in many of
the defects studied, and contributes to the hyperkeratotic
phenotype observed in ichthyosis.
MATERIALS AND METHODS
Antibody preparation Puri®ed TGase 5 recombinant enzyme (Candi
et al, 2001) was used to produce polyclonal antibodies in rats. The
enzyme was puri®ed to homogeneity using metal af®nity
chromatography and 200 mg of the puri®ed enzyme was used to raise
speci®c rat polyclonal antibodies. All procedures involving patients,
animals, and their care followed institutional guidelines in compliance
with national and international laws and policies (EEC Council Directive
86/109, OJL 358, December 1, 1987, and D.L. January 1992, n.116).
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Two Sprague-Dawley male rats, weighing 150±180 g, were subcuta-
neously injected with 25 mg (50 ml) of antigen adsorbed onto 20 ml of
aluminum hydroxide (Pierce). The mixture was injected weekly for
three consecutive weeks. The booster dose was administered 15 d after
the last inoculation. Four days after the booster injection the antiserum
was collected from the animals by tail bleed and tested to determine the
strength of the speci®c antibody response.
Keratinocyte transfections Cryopreserved normal human epidermal
keratinocytes were obtained from BioWhittaker and grown in bovine-
skin-collagen-coated dishes in serum-free keratinocyte medium at
0.05 mM Ca2+, supplemented with 7.5 (mg per ml) bovine pituitary
extract, insulin (0.5 mg per ml), hydrocortisone (0.5 mg per ml), and
human epidermal growth factor (0.1 UG per ml). Third passage cells
were used for transfection experiments. Transient transfections of
pCDNA3.1±TGase 5 were performed using Effectene (Candi et al, 2001)
as described previously. Brie¯y, 8 3 105 keratinocytes were plated in
collagen-coated 100 mm dishes 1 d before transfection. Transfected cells
were kept for 2 d in culture. For confocal microscopy, keratinocytes
were plated on collagen-coated cover glass, transfected with an
equivalent ratio cell/DNA/lipid reagent, and kept in culture for 2 d.
Cells were then collected and analyzed by Western blot and confocal
microscopy.
Western blotting Western blots were performed using the whole cells
or insoluble extracts from infected Sf9 insect cells or normal human
epidermal keratinocytes; the blots (polyvinylidene di¯uoride membrane)
were kept in blocking solution (10% dried milk, 5% bovine serum
albumin) for 2 h at room temperature. Blots were incubated, shaking, for
2 h at room temperature with the anti-TGase 5 rat serum (dilution
1:200 or 1:1000, to detect native or overexpressed TGase 5). After three
washes in PBS±Tween 20 (0.05%) secondary antibody was added
(1:20,000 dilution in blocking solution). Proteins were detected using
the enhanced chemiluminescence method. Antibody-competition
experiments were performed by pretreating anti-TGase 5 antiserum with
200 mg of insoluble normal human epidermal keratinocyte (grown in
differentiating conditions) cell extract for 1 h at 4°C, in the presence of a
protease inhibitor cocktail to avoid degradation. For immuno-
crossreactivity evaluation with other TGases, we used baculovirus
expressed TGase 1 (Candi et al, 1998), puri®ed guinea-pig liver TGase 2
(Sigma Chemical), and the baculovirus expressed TGase 3 (a kind gift of
Dr. P.M. Steinert).
Indirect immuno¯uorescence and confocal analysis Normal and
defective adult trunk skin samples were paraf®n embedded and cut into
sections 6 mm thick. Human skin biopsies were performed for diagnostic
purposes and ®ve sections were used for research following a well-
Figure 1. Characterization of anti-TGase 5
antiserum. (A) Normal human epidermal
keratinocytes were transfected using pCDNA3.1
vector bearing c-myc tagged TGase 5 cDNA.
TGase 5 protein was then detected in transfected
cells by confocal microscopy, using anti-c-myc
antibody and anti-TGase 5 antiserum.
Superimposition of the images shows that the two
antibodies recognize the same protein (yellow).
Bar: 10 mm. Anti-serum speci®city was also
assayed by Western blot. (B) Western blot
performed on noninfected (lane 1, lane 3 control)
and infected Sf9 cells using anti-c-myc antibody
and anti-TGase 5 antiserum (respectively, lanes 2,
4). (C) Western blot performed on transfected
normal human epidermal keratinocytes using anti-
c-myc and anti-TGase 5 antibody (lanes 2 and 3,
respectively). The anti-TGase 5 antiserum was
incubated with an insoluble keratinocyte extract
(which contains native TGase 5) prior to TGase 5
detection by Western blotting (D). Numbers
below the bands indicate relative band intensities
evaluated by semiquantitative scanning.
(E)Western blot of TGase 1, 2, 3, and 5 (0.2 mg
each enzyme) using anti-TGase 5 antibody.
Normal human epidermal keratinocytes were
grown in proliferating (0.05 mM calcium, F) and
in differentiating (1.2 mM calcium, G) conditions
for 24 h. Expression of native TGase 5 was then
evaluated by confocal microscopy using our
speci®c anti-TGase 5 antiserum. Antigen-
competition experiments on confocal
immuno¯uorescence are shown in (H). The anti-
TGase 5 antiserum was incubated with an
insoluble keratinocyte extract (which contains
native TGase 5) prior TGase 5 detection by
confocal microscopy. Bar: 10 mm. The
experiments shown are representative of three to
®ve experiments.
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informed consent by the patient. The ethical committee of the hospital
approved the study. Sections were permeabilized with 0.1% Triton X-
100 for 3 min at room temperature and blocked using 10% bovine
serum albumin (BSA) in phosphate-buffered saline (PBS) overnight at
+4°C. Sections were then incubated with rat anti-TGase 5 antibodies
diluted 1:20 in 10% BSA solution and antikeratin 14 (Babco) and anti-
TGase 3 antibodies (kind gift of Dr. Soo Kim) diluted, respectively,
1:100 and 1:1000. Lamellar ichthyosis (LI) skin sections were also stained
with anti-TGase 1 antibody (kind gift of Dr. Soo Kim) following the
conditions described in Kim et al (1995). Antibody-competition
experiments were performed by pretreating anti-TGase 5 antiserum with
200 mg of insoluble normal human epidermal keratinocyte (grown in
differentiating conditions) cell extract for 1 h or overnight at 4°C, in the
presence of a protease inhibitor cocktail to avoid degradation. After
washing three times in PBS, sections were incubated for 1 h with
secondary antiserum (goat antirat Alexa Fluor 488 or Alexa Fluor 568)
diluted in 10% BSA solution 1:1000. Sections were then mounted using
Prolong Antifade kit. Fluorescence was evaluated with a confocal
microscope (Nikon Instruments Spa, Eclipse TE200), exciting at 488 nm
with an Ar laser and at 542 nm with an He laser. The software used was
EZ2000 for PCM2000.
RESULTS AND DISCUSSION
Characterization of the anti-TGase 5 antiserum To assess
anti-TGase 5 antibody speci®city, we transfected normal human
epidermal keratinocytes (Candi et al, 2001) with the pCDNA3.1
vector, bearing c-myc tagged TGase 5 cDNA. TGase 5 protein was
then detected in transfected cells by confocal microscopy, using
anti-c-myc antibody and our novel anti-TGase 5 antiserum.
Figure 1(A) shows that anti-TGase 5 and anti-c-myc antibodies
recognized the same protein as indicated by the appearance of
yellow in image superimposition. The signal detected by anti-
TGase 5 antibody that did not overlap perfectly (see green staining,
Fig 1A) with the signal detected by anti-c-myc antibody (see red
staining, Fig 1A) is probably due to endogenous TGase 5 in
normal keratinocytes. The anti-TGase 5 antibody speci®city has
been con®rmed by Western blot analysis of Sf9 cells infected with
recombinant baculovirus bearing c-myc tagged TGase 5 cDNA
(Fig 1B). Western blots were performed on total cellular extract
using antitag antibody (Fig 1B, lane 1, control; lane 2, anti-c-myc)
and anti-TGase 5 antibodies (Fig 1B, lane 3, control; lane 4, anti-
TGase 5). As already described by the confocal analysis, results
indicate that the same bands are recognized by the two antibodies,
one of 84 kDa, which is the monomeric form of the enzyme, and a
200 kDa band that is obtained by the autocatalytic activity of TGase
5 (Candi et al, 2001). The high molecular weight band is probably
due to autocatalytic activity of TGases, as already described for
TGase 2 and factor XIIIa (Barry and Mosher, 1990). In addition,
another less intense 30 kDa band appears. Identical results were
obtained using insoluble keratinocyte extract. A Western blot of
transfected TGase 5 detected using anti-TGase 5 antibody (Fig 1C,
lane 2) and anti-c-myc antibody (Fig 1C, lane 3) showed a similar
pattern, with the control of nontransfected normal human
epidermal keratinocytes shown in lane 1. Note that native TGase
5 is not detected by Western blot in keratinocytes grown in
proliferating conditions (lane 1). A faint band of 84 kDa is detected
in keratinocytes grown in differentiating conditions (data not
shown). This suggests that, as already described for TGase 3, TGase
5 is poorly expressed in in vitro differentiating keratinocytes. The
additional bands present in lane 2 are probably due to degradation as
they are not observed in other experimental conditions.
To verify the speci®city of the bands detected by Western blot,
we performed antigen-competition experiments. The anti-TGase 5
antiserum was incubated with an insoluble keratinocyte extract
(which contained native TGase 5) for 1 h at +4°C, prior to TGase
5 detection by Western blotting. Results showed that insoluble
keratinocyte extract competes with the recognition of all three
bands detected (84 kDa, 200 kDa, and 30 kDa, Fig 1D), reducing
them by between 3-fold and 11-fold as indicated by quantitative
scanning analysis of the bands.
Figure 2. TGase 5 expression in normal
human epidermis. Speci®city of the anti-TGase
5 antiserum was tested in paraf®n-embedded skin
sections. We stained skin sections using anti-
TGase 5 antiserum (diluted 1:200; A), preimmune
rat antiserum (diluted 1:200; B), and pretreated
anti-TGase 5 antiserum (®nal dilution 1:200; C).
The staining obtained using the preimmune rat
serum shows very low background (B), in
comparison with the staining obtained with the
anti-TGase 5 (A). The latter is almost completely
abolished using pretreated anti-TGase 5 antiserum
(incubated before staining with native and/or
recombinant TGase 5 for 1 h or overnight at
+4°C; C). Skin sections from normal skin were
taken and evaluated by confocal microscopy using
speci®c anti-TGase 5 antiserum (D, G), anti-
keratin-14 antibody (H), and anti-TGase 3
antibody (E). Image superimpositions of TGase 5/
TGase 3 and TGase 5/keratin 14 staining are
shown (F, I, merge). These images are
representative of ®ve patients analyzed for each
disease. Bars: 20 mm (D±I), 15 mm (A±C).
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In human epidermis, at least four TGases are expressed. Whereas
TGase 2 has been detected only in the basal layer, the others
(TGase 1, TGase 3, and TGase 5) are expressed in the upper layers.
To evaluate whether our TGase 5 antiserum crossreacts with the
other TGases we performed a Western blot using puri®ed native or
recombinant TGase 1, TGase 2, TGase 3, and TGase 5 as positive
control. The staining, shown in Fig 1(E), revealed that anti-TGase
5 antiserum does not crossreact with the other TGases known to be
expressed in human skin but recognizes only recombinant TGase 5
as an 84 kDa band (full length) and a higher molecular weight band
of about 200 kDa that probably represents the auto-crosslinking
product of TGase 5 (Candi et al, 2001).
In our previous studies we have shown that TGase 5 plays a role
in in vitro keratinocyte differentiation (Candi et al, 2001). To
con®rm this, we performed confocal analysis on cultured human
keratinocytes grown in proliferating and differentiating conditions.
We observed that keratinocytes grown in vitro in proliferating
conditions (0.05 mM calcium) expressed a very low level of TGase
5 (Fig 1F), whereas the addition of calcium to the growth medium
(1.2 mM) enhances TGase 5 expression (Fig 1G), with some cells
intensively stained compared to other cells. Pretreated antiserum
(incubated for 1 h at +4°C with native TGase 5) shows a consistent
reduction of the signal (Fig 1H), con®rming the speci®city of anti-
TGase 5 antibody in the experimental conditions used.
TGase 5 expression in normal human epidermis To verify
the speci®city of the anti-TGase 5 antiserum in paraf®n-embedded
sections, we stained skin sections using anti-TGase 5 antiserum
(diluted 1:200; Fig 2A), preimmune rat antiserum (diluted 1:200;
Fig 2B), and pretreated anti-TGase 5 antiserum (®nal dilution
1:200). As shown in Fig 2(A), (D), results indicated that the
immuno¯uorescences performed using anti-TGase 5 antiserum are
speci®c. Indeed, the staining obtained using the preimmune rat
serum shows very little background (Fig 2B), whereas the staining
obtained with the anti-TGase 5 antiserum is strong (Fig 2A). The
latter is almost completely abolished using pretreated anti-TGase 5
antiserum (incubated before staining with native and/or
recombinant TGase 5 for 1 h or overnight at +4°C; Fig 2C),
indicating the speci®city of the staining shown in Fig 2(A), (D). As
we observed very low background in Fig 2(B) and speci®city in
the staining shown in Fig 2(A), demonstrated by the blocking
experiments, we decided not to af®nity-purify the antiserum.
In normal epidermis, TGase 5 antibody decorated the upper
layers, with consistent staining in the spinous and granular layers
(Fig 2D, G), and the enzyme was also detected in the basal layer at
very low levels (Fig 2A, D, G). TGase 3 is expressed in the upper
granular layer (Fig 2E) whereas TGase 5 expression follows a
gradient from the spinous to the granular layers (Fig 2A, D) and
therefore appears in the early stage of epidermal differentiation.
TGase 3 and TGase 5 expression in normal skin overlapped mainly
in a restricted area of the granular layer (Fig 2D±F) as shown by
the appearance of yellow staining in Fig 2(F). In human dermis,
positive immuno¯uorescent staining is observed in the erythro-
cytes, suggesting that the novel anti-TGase 5 antibody might
crossreact with band 4.2, which is another member of the TGase
family. This crossreactivity it is not crucial for our studies, however;
in fact band 4.2 is exclusively present in the red cells.
TGase 5 expression in psoriasis Psoriasis is a chronic skin
disorder characterized by marked hyperproliferation and altered
differentiation of keratinocytes in the context of activated cell-
mediated immunity and in¯ammation (Barker, 1991).
Histopathologic features consist of achantosis, parakeratosis,
papillomatosis, and in¯ammatory in®ltrates. In Fig 3(A), (B) we
can observe some of these features in hematoxylin±eosin stained
psoriatic sections taken from one of the patients analyzed. The
pathophysiology of this disease remains unknown, however,
although an alteration in cell±cell and cell±matrix adhesion versus
Figure 3. TGase 5 expression in psoriasis.
Skin sections from psoriatic patients were taken
and evaluated by confocal microscopy using
speci®c anti-TGase 5 antiserum (C, F), anti-
keratin-14 antibody (G), and anti-TGase 3
antibody (D). Image superimpositions of TGase 5/
TGase 3 and TGase 5/keratin 14 staining are
shown (E, H, merge). Lower magni®cations of
hematoxylin±eosin staining of serial sections are
included (A, B). Bars: 80 mm (A), 50 mm (B),
20 mm (C±H).
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an autoimmune process has been proposed as the primary defect
(Fleischmajer et al, 2000). Figure 3 shows a series of sections of
psoriatic human skin examined using indirect immuno¯uorescence.
We analyzed ®ve unrelated psoriasis patients and obtained a very
similar expression pattern in all of them for the analyzed molecules
(TGase 3, TGase 5, and keratin 14). Immuno¯uorescence staining
using anti-keratin-14 antibody indicated that keratinocyte
differentiation is indeed abnormal in the skin of the analyzed
patients: keratin 14 can be detected in every layer (Fig 3G),
including the horny layer, where parakeratosis is also evident.
TGase 5 expression in psoriatic lesions appears similar to normal
(Fig 3C±E, F); in fact it is possible to observe the gradient of
expression from the lower to the upper layers. TGase 5 seems
overexpressed in some areas (Fig 3C, F), however, whereas the
same is not true for TGase 3. This observation could also be due to
the increased number of layers in the psoriatic lesion studied, and
suggests that the involvement of TGase 5 in this pathogenesis is
mainly secondary. TGase 3 expression appears downregulated in all
sections analyzed, con®rming the altered differentiation program in
psoriatic keratinocytes.
TGase 5 expression in ichthyosis vulgaris Ichthyosis vulgaris
is an autosomal dominant skin disorder of keratinization
characterized histologically by absent or reduced keratohyaline
granules in the epidermis and mild hyperkeratosis (Anton-
Lamprecht and Hofbauer, 1972; Sybert et al, 1985). Affected skin
appears dry and scaly. The basic molecular defect of ichthyosis
vulgaris is unknown. Immunohistochemistry of skin samples taken
from patients affected by ichthyosis vulgaris revealed that ®laggrin,
and its precursor pro-®laggrin, may have a role in the pathogenesis.
In fact, ®laggrin is not present in the more severely affected patients
(Sybert et al, 1985). In order to evaluate TGase 5 expression in this
disease, we analyzed samples from four different patients affected by
ichthyosis vulgaris and found that in one patient TGase 5
expression was similar to normal epidermis (Fig 4D±F), being
expressed as a gradient that stained more intensively in the upper
layer. In other patients, however, TGase 5 seems to contribute to
the hyperkeratotic phenotype observed in ichthyosis vulgaris
(Fig 4A, B, white arrows). This observation is even more
interesting if we consider TGase 3 expression (Fig 4B); in fact,
in the patients studied, it was observed that, whereas TGase 3
expression is not altered (Fig 4B), TGase 5 is clearly overexpressed
and several keratinocytes in the spinous layer present a very intense
staining (Fig 4A, arrows). Figure 4(G), (H) shows hematoxylin±
eosin staining of serial sections of the patient corresponding to Fig
3(D)±(F).
TGase 5 expression in LI LI is part of congenital recessive
ichthyosis, which includes the heterogeneous class of disorders of
corni®cation that affect epidermis and hair. The clinical phenotype
can range from generalized large brownish plate-like scales to ®ne
white scales with underlying erythroderma. Many patients also
exhibit ectropion and eclabian due to tautness of the facial skin.
Histopathologic ®ndings show orthokeratotic hyperkeratosis and
mild to moderate acanthosis (Traupe et al, 1984; Williams and Elias,
1985; 1993; Williams, 1992). Mutations in the gene coding for
TGase 1 enzyme, TGM1, have been reported in LI patients,
providing compelling evidence for the importance of TGases for
the correct assembly of the CE and therefore for the homeostasis of
the epidermis (Huber et al, 1995; Russell et al, 1995). Since then,
several different mutations of TGM1 have been identi®ed
(Parmentier et al, 1995; Huber et al, 1997; Laiho et al, 1997; Petit
et al, 1997; Bichakjian et al, 1998; Esposito et al, 2001; Yang et al,
2001). Biochemical data clearly showed that about 50%±60% of LI
patients have normal TGase activity (Huber et al, 1995a), however,
suggesting a genetic heterogeneity of the disorder. Genetic
heterogeneity is further supported by genetic mapping studies
identifying, beside chromosome 14q11 where TGM1 is located, a
Figure 4. TGase 5 expression in ichthyosis
vulgaris. Skin sections from affected patients
were taken and evaluated by confocal microscopy
using speci®c anti-TGase 5 antiserum (A, D),
anti-keratin-14 antibody (E), and anti-TGase 3
antibody (B). Image superimpositions of TGase 5/
TGase 3 and TGase 5/keratin 14 staining are
shown (C, F, merge). White arrows in panels A and
D indicate cells with higher staining. Lower
magni®cations of hematoxylin±eosin staining of
serial sections are included (G, H). Bars: 80 mm
(G), 50 mm (H), 20 mm (A±F).
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Figure 5. TGase 5 expression in LI. Skin
sections from affected patients were taken and
evaluated by confocal microscopy using speci®c
anti-TGase 5 antiserum (A, D), anti-keratin-14
antibody (E), and anti-TGase 3 antibody (B).
Image superimpositions of TGase 5/TGase 3 and
TGase 5/keratin 14 staining are shown (C, F,
merge). White arrows in panels A and D indicate
cells with high staining. Anti-TGase 1 staining is
shown in G.Lower magni®cations of
hematoxylin±eosin staining of sections of affected
skin are included (H, I). Bars: 80 mm (panel H),
50 mm (panel I), 20 mm (panels A±G).
Figure 6. TGase 5 expression in DD. Skin
sections from affected patients were taken and
evaluated by confocal microscopy using speci®c
anti-TGase 5 antiserum (A, D), anti-keratin 14
antibody (E), and anti-TGase 3 antibody
(B).Image superimpositions of TGase 5/TGase 3
and TGase 5/keratin 14 staining are shown (C, F,
merge). Lower magni®cations of hematoxylin±
eosin staining of serial sections are included (A,
B). Bars: 80 mm (A), 50 mm (B), 60 mm (C±H).
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second locus at chromosome 2q33±35 (Parmentier et al, 1996) and
the existence of a third gene apparently unlinked to the above
chromosomes (14 and 2; Bale et al, 1996; Parmentier et al, 1996).
We analyzed ®ve patients affected by LI. Before starting our
studies we investigated whether the diseases were due to mutations
in the TGM1 gene by biochemical measurement of the TGase
activity in patient keratinocytes kept in culture (data not shown).
We found that two out of ®ve patients had 80%±90% reduction in
TGase activity indicating that mutations in TGM1 are responsible
for LI in these patients, whereas the remaining three had normal
TGase activity comparing to normal control suggesting that TGM1
is not the gene involved in the pathogenesis.
In all samples analyzed, from ®ve LI patients, TGase 5 expression
is upregulated (Fig 5A, D) independently of the involvement of
TGase 1 enzyme in the pathogenesis. In Fig 5 we show the
immuno¯uorescence of two patients with normal TGase activity in
cultured keratinocytes. TGase 1 immuno¯uorescent staining for
one of them is shown in Fig 5(G) and appears similar to the normal
pattern described previously in normal human epidermis (Kim et al,
1995). Most of the keratinocytes in the upper layers appear
intensively stained (Fig 5A, D, arrows) in LI patients compared to
keratinocytes in the upper layers of normal skin (Fig 2A, D, G).
TGase 3 expression is also upregulated (Fig 5B) in all the ®ve
patients studied, and staining is detected in granular and spinous
layers (Fig 5D±F). Keratin 14 expression appears similar to normal
skin; very faint not speci®c staining appeared in the stratum
corneum. Figure 4(H), (I) shows hematoxylin±eosin staining of a
patient affected by LI.
TGase 5 expression in DD Finally, we investigated patients
affected by DD. DD is an autosomal dominant skin disorder
characterized by loss of adhesion between epidermal cells
(acantholysis) and abnormal keratinization (Burge and Wilkinson,
1992). DD patients develop warty papules and plaques on the
central trunk, scalp, forehead, and ¯exure. The typical histologic
features include focal areas of separation between suprabasal
epidermal cells and abnormal keratinization; some of these
features can be observed in Fig 6(A), (B), which shows
hematoxylin±eosin staining of affected skin.
Immunohistopathology and electron microscopy reveal loss of
desmosomal attachments and perinuclear aggregations of keratin
®laments (Burge and Garrod, 1991). Recently, mutations in a
speci®c Ca2+ pump ATPase (ATP2A2) have been indicated as the
defective gene for DD (Anavaj et al, 1999). In all the patients that
we analyzed (four) we observed that both TGase 3 and TGase 5
expression altered (Fig 6C±F). TGase 5, for instance, appeared
upregulated in some areas of the lesion (Fig 6F) but was almost
absent in others (Fig 6C). Keratin 14 expression appeared normal;
in addition to the normal keratin 14 expression observed in the
proliferative layer, low level keratin 14 expression was observed in
the upper layers (Fig 6G), probably due to nonspeci®c staining.
Concluding remarks Although the expression pattern of the
TGase 5 enzyme is not exclusively restricted to the epidermis
(Aeschlimann et al, 1998; Grenard et al, 2001; Candi et al, 2001),
previous in vitro studies, by us and others (Aeschlimann et al, 1998;
Candi et al, 2001), have indicated that TGase 5 contributes to
keratinocyte differentiation and CE assembly. To con®rm these
studies, we made an anti-TGase 5 antiserum and we demonstrated
the speci®city of this antibody by Western blot and
immuno¯uorescence techniques both on cultured keratinocytes
and in paraf®n-embedded skin sections.
We performed indirect immuno¯uorescence on normal human
skin, and the results obtained indicated that TGase 5 is expressed
in vivo in human epidermis in the spinous and granular layers, but it
is also detectable at very low levels in the basal layer. This
observation is very important and supports our early in vitro data
(Candi et al, 2001), which showed that TGase 5 enzyme is ef®cient
in crosslinking speci®c epidermal substrates such as loricrin, SPRs,
and involucrin to the same extent as TGase 1 and TGase 3. In
addition, we investigated skin diseases where the keratinization
process is impaired such as ichthyosis (ichthyosis vulgaris and LI)
and DD. We also analyzed samples from patients affected by
psoriasis, where hyperproliferation and altered differentiation of
keratinocytes are both present. Our data suggested that TGase 5 is
not directly involved in the pathogenesis of these diseases, and
although its expression is altered, it seems to contribute consist-
ently, even though as a secondary event, to the hyperkeratotic
phenotype observed. This is evident in skin samples from patients
affected by LI and ichthyosis vulgaris, as well as for some samples
from psoriatic lesions. In DD, TGase 5 expression, as well as TGase
3, is completely altered, being overexpressed or totally absent in
different areas of the same lesion.
These results strongly indicate that TGase 5 plays an important
role in the homeostasis of the epidermis, and when the function of
the epithelia is compromised (as occurs in the diseases studied),
overexpression of TGase 5 contributes to the hyperkeratotic
phenotype, possibly as a compensation mechanism of the abnormal
epidermis.
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